196 related articles for article (PubMed ID: 31426735)
41. [Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections].
Eser OK; Altun Uludağ H; Ergin A; Boral B; Sener B; Hasçelik G
Mikrobiyol Bul; 2014 Jan; 48(1):59-69. PubMed ID: 24506716
[TBL] [Abstract][Full Text] [Related]
42. Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).
Lu PL; Liu YC; Toh HS; Lee YL; Liu YM; Ho CM; Huang CC; Liu CE; Ko WC; Wang JH; Tang HJ; Yu KW; Chen YS; Chuang YC; Xu Y; Ni Y; Chen YH; Hsueh PR
Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S37-43. PubMed ID: 22749057
[TBL] [Abstract][Full Text] [Related]
43. Prevalence and molecular characterization of carbapenemase-producing gram-negative bacteria from a university hospital in China.
Sun Y; Li M; Chen L; Chen H; Yu X; Ye J; Zhang Y; Ma C; Zhou T
Infect Dis (Lond); 2016 Feb; 48(2):138-46. PubMed ID: 26463362
[TBL] [Abstract][Full Text] [Related]
44. Antimicrobial resistance of gram-negative bacteria: A six-year longitudinal study in a hospital in Saudi Arabia.
Al-Tawfiq JA; Rabaan AA; Saunar JV; Bazzi AM
J Infect Public Health; 2020 May; 13(5):737-745. PubMed ID: 32008927
[TBL] [Abstract][Full Text] [Related]
45.
Castanheira M; Davis AP; Mendes RE; Serio AW; Krause KM; Flamm RK
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866862
[TBL] [Abstract][Full Text] [Related]
46. Comparison of Antimicrobial Susceptibility Test Results of Disk Diffusion, Gradient Strip, and Automated Dilution with Broth Microdilution for Piperacillin-Tazobactam.
Gehring T; Kim HJ; Dibloni E; Neuenhoff M; Buechler C
Microb Drug Resist; 2021 Oct; 27(10):1305-1311. PubMed ID: 34582726
[TBL] [Abstract][Full Text] [Related]
47. [Report of antimicrobial resistance surveillance program in Chinese children in 2016].
Wang CQ; Wang AM; Yu H; Xu HM; Jing CM; Deng JK; Zhao RZ; Hua CZ; Chen YH; Chen XJ; Zhang T; Zhang H; Chen YP; Yang JG; Lin AW; Wang SF; Cao Q; Wang X; Deng HL; Cao SC; He JH; Gao W; Han SZ
Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):29-33. PubMed ID: 29342994
[No Abstract] [Full Text] [Related]
48. Prevalence study on carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates in Czech hospitals--results from Czech Part of European Survey on Carbapenemase--Producing Enterobacteriaceae (EuSCAPE).
Hrabák J; Študentová V; Jakubů V; Adámková V; Dvořáková L; Balejova M; Bergerová T; Chmelařová E; Ježek P; Kabelíková P; Kolář M; Paterová P; Tejkalová R; Papagiannitsis C; Žemličková H
Epidemiol Mikrobiol Imunol; 2015 Jun; 64(2):87-91. PubMed ID: 26099612
[TBL] [Abstract][Full Text] [Related]
49. Multicenter Evaluation of the New Etest Gradient Diffusion Method for Piperacillin-Tazobactam Susceptibility Testing of
García-Fernández S; Bala Y; Armstrong T; García-Castillo M; Burnham CA; Wallace MA; Hardy D; Zambardi G; Cantón R
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31597745
[TBL] [Abstract][Full Text] [Related]
50. Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Zhang H; Yang Q; Liao K; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Hu Z; Chu Y; Chen S; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Badal RE; Xu Y
Antimicrob Agents Chemother; 2016 Jan; 60(1):245-51. PubMed ID: 26482308
[TBL] [Abstract][Full Text] [Related]
51. Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China.
Guo W; He Q; Wang Z; Wei M; Yang Z; Du Y; Wu C; He J
Am J Infect Control; 2015 Apr; 43(4):358-64. PubMed ID: 25838134
[TBL] [Abstract][Full Text] [Related]
52. National survey of colistin resistance among carbapenemase-producing Enterobacteriaceae and outbreak caused by colistin-resistant OXA-48-producing Klebsiella pneumoniae, France, 2014.
Jayol A; Poirel L; Dortet L; Nordmann P
Euro Surveill; 2016 Sep; 21(37):. PubMed ID: 27685838
[TBL] [Abstract][Full Text] [Related]
53. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF
J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952
[TBL] [Abstract][Full Text] [Related]
54. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
[TBL] [Abstract][Full Text] [Related]
55. The distribution of carbapenem- and colistin-resistance in Gram-negative bacteria from the Tamil Nadu region in India.
Manohar P; Shanthini T; Ayyanar R; Bozdogan B; Wilson A; Tamhankar AJ; Nachimuthu R; Lopes BS
J Med Microbiol; 2017 Jul; 66(7):874-883. PubMed ID: 28671537
[TBL] [Abstract][Full Text] [Related]
56. Australian Group on Antimicrobial Resistance Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2014.
Coombs GW; Daley DA; Thin Lee Y; Pearson JC; Robinson JO; Nimmo GR; Collignon P; Howden BP; Bell JM; Turnidge JD;
Commun Dis Intell Q Rep; 2016 Jun; 40(2):E244-54. PubMed ID: 27522136
[TBL] [Abstract][Full Text] [Related]
57. Dual-tubed multiplex-PCR for molecular characterization of carbapenemases isolated among Acinetobacter spp. and Pseudomonas spp.
Kazi M; Nikam C; Shetty A; Rodrigues C
J Appl Microbiol; 2015 May; 118(5):1096-102. PubMed ID: 25647446
[TBL] [Abstract][Full Text] [Related]
58. Molecular characteristics of carbapenem-resistant gram-negative bacteria in southern China.
Zheng F; Sun J; Cheng C; Rui Y
Microb Drug Resist; 2015 Apr; 21(2):178-85. PubMed ID: 25469995
[TBL] [Abstract][Full Text] [Related]
59. In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme.
Karlowsky JA; Lob SH; Kazmierczak KM; Hawser SP; Magnet S; Young K; Motyl MR; Sahm DF
J Antimicrob Chemother; 2018 Jul; 73(7):1872-1879. PubMed ID: 29659861
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of antimicrobial resistances in common pathogenic Enterobacteriaceae in Australia, 2004: report from the Australian Group on Antimicrobial Resistance.
Pearson J; Turnidge J; Franklin C; Bell J;
Commun Dis Intell Q Rep; 2007 Mar; 31(1):106-12. PubMed ID: 17503650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
